Abstract:Chengjie Zhong, 1, &ast Jiajiu Chen, 2, &ast Yi Ling, 3 Deng Liu, 3 Jing Xu, 2 Luofu Wang, 2 Chengguo Ge, 4 Qing Jiang 4 1 The Second Clinical Medical College, Chongqing Medical University, Chongqing, 400016, People's Republic of China; 2 Department of Urology, Daping Hospital, Army Medical University, Chongqing, 400038, People's Republic of China; 3 Department of Ultrasound, Southwest Hospital, Army Medical University, Chongqing, 400042, People's Republic of China; 4 Department of Urology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chengguo Ge; Qing Jiang, Department of Urology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, People's Republic of China, Tel +86 13883510963 ; +86 13508346066, Email ; Background and Purpose: The early diagnosis and differential diagnosis of renal cell carcinoma (RCC) has always been a clinical difficulty and a research focus. Carbonic anhydrase IX (CA IX) is highly expressed on the cell membrane of RCC but is not expressed in normal renal tissues. In this study, nanobubbles (NBs) targeting CA IX with ultrasound and photoacoustic multimodal imaging capabilities were prepared to explore a new method for the diagnosis and differential diagnosis of RCC. Methods: Indocyanine green (ICG)-loaded lipid NBs (ICG-NBs) were prepared by using the filming rehydration method, and anti-CA IX polypeptides (ACPs) were attached to their surfaces to prepare CA IX-targeted NBs (ACP/ICG-NBs). The particle size, zeta potential and ICG encapsulation efficiency of these nanobubbles were measured, and their specific targeting and binding abilities to RCC cells were determined. The in vitro and in vivo ultrasound, photoacoustic and fluorescence imaging characteristics of these nanobubbles were also assessed. Results: The particle size of the ACP/ICG-NBs was 475.9 nm in diameter, and their zeta potential was − 2.65 mV. Laser confocal microscopy and flow cytometry both confirmed that ACP/ICG-NBs had specific binding activity and ideal affinity to CA IX-positive RCC cells (786-O) but not to CA IX-negative RCC cells (ACHN). The intensities of the in vitro ultrasound, photoacoustic and fluorescence imaging were positively correlated with the concentrations of ACP/ICG-NBs. In in vivo ultrasound and photoacoustic imaging experiments, ACP/ICG-NBs exhibited specific enhanced ultrasound and photoacoustic imaging effects in 786-O xenograft tumors. Conclusion: The ICG- and ACP-loaded targeted nanobubbles that we prepared had the capability of ultrasound, photoacoustic and fluorescence multimodal imaging and could specifically enhance the ultrasound and photoacoustic imaging of RCC xenograft tumors. This outcome has potential clinical application value for the diagnosis of RCC at the early stage and the differential diagnosis of benign and malignant kidney tumors. Keywords: contrast-enhanced ultrasound imaging, photoacoustic imaging, renal cell carcinoma, carbonic anhydrase IX, targeted nanobubble, fluorescence imaging Renal cell carcinoma (RCC) originates from renal tubular epithelial cells and is responsible for approximately 90% of all renal malignancies. 1,2 However, due to the deep location of the kidney, the early clinical manifestations of RCC are insidious, and the patients exhibit no obvious symptoms. More than 16% of patients develop distant metastasis at the time of the initial diagnosis. 3 At present, the diagnosis of RCC mainly relies on imaging examinations, including color Doppler ultrasound, computerized tomography (CT, including enhanced CT) and magnetic resonance imaging (MRI). 4 In fact, it is not difficult to detect renal tumors via imaging examinations; however, the differentiation between benign and malignant tumors (especially small renal tumors) often makes it difficult to provide clear conclusions due to the lack of specificity. It is not uncommon for benign tumors to be misdiagnosed as RCC, and nephrectomy is subsequently performed. 5,6 Therefore, the early and accurate diagnosis of RCC and differential diagnosis of benign and malignant renal tumors are still clinical difficulties and research priorities. Color Doppler ultrasonography is the preferred method for the diagnosis of renal space-occupying lesions. 7 It has the characteristics of high resolution, a lack of radiation and real-time dynamic observations. However, conventional color Doppler ultrasonography is not ideal for tumor characterization. Contrast-enhanced ultrasound -Abstract Truncated-

Dynamic monitoring of tumor formation in nude mice bearing human renal carcinoma xenograft using targeted nanobubbles carrying CAⅨ polypeptide

Study on the Therapeutic Efficacy of Subcutaneous Pancreatic Cancer Xenograft Tumor with Ultrasound Destruction of Different Size Microbubbles

Characteristics of VEGFR2-targeted Lipid Microbubbles Contrast-Enhanced Ultrasound in Nude Mice with Subcutaneous Colonic Carcinoma Xenografts: Compared with Lipid Microbubbles

Study on Hypovascular Tumor' S Treatment with Targeted Mierobubbles Combined with Ultrasonic Abrupted Destroy

Targeted Contrast-Enhanced Ultrasound in the Assessment of Renal Cell Carcinoma Angiogenesis in Nude Mice

Molecular ultrasound imaging with vascular endothelial growth factor receptor 2-targeted microbubbles in a mouse liver cancer model

Ultrasound Molecular Imaging of Breast Cancer in MCF-7 Orthotopic Mice Using Gold Nanoshelled Poly(lactic-Co-glycolic Acid) Nanocapsules: a Novel Dual-Targeted Ultrasound Contrast Agent.

Preparation of Lipid Nano-Bubbles as Contrast Agent Material for Tumor Ultrasound Diagnosis of Breast Cancer

An Experimental Study on Anti-Tumor Effect of Low Frequency Ultrasound Radiation with Microbubbles on Human Prostate Carcinoma Xenograft in Nude Mice

Effect of contrast-enhanced ultrasound imaging of VEGFR2 targeted microbubbles in murine renal tumor model

Ultrasensitive Optical Detection and Elimination of Residual Microtumors with a Postoperative Implantable Hydrogel Sensor for Preventing Cancer Recurrence.

Dual-Functional Nanodroplet for Tumor Vasculature Ultrasound Imaging and Tumor Immunosuppressive Microenvironment Remodeling

Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature

Indocyanine Green-Loaded Nanobubbles Targeting Carbonic Anhydrase IX for Multimodal Imaging of Renal Cell Carcinoma

Ultrasound Targeted Apoptosis Imaging in Monitoring Early Tumor Response of Trastuzumab in A Murine Tumor Xenograft Model of Her-2-Positive Breast Cancer

Photoacoustic imaging biomarkers for monitoring biophysical changes during nanobubble-mediated radiation treatment

Nanotechnology and cancer: improving real-time monitoring and staging of bladder cancer with multimodal mesoporous silica nanoparticles

Effects of low-frequency ultrasound and microbubbles on angiogenesis-associated proteins in subcutaneous tumors of nude mice.

Real Time Ultrasound Molecular Imaging of Prostate Cancer with PSMA-targeted Nanobubbles

Annexin V Conjugated Nanobubbles: A Novel Ultrasound Contrast Agent for in Vivo Assessment of the Apoptotic Response in Cancer Therapy

Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA